Published

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Cochrane database of systematic reviews
Date: 2024-09-12
Source: PubMed
DOI: 10.1002/14651858.cd015383.pub2
PubMed: 39260823

Authors

Schipper S Nigam K Schmid Y Piechotta V Ljuslin M Beaussant Y Schwarzer G Boehlke C

Watch author

Derived topics and classifications

psilocybin Depression Anxiety End-of-Life Distress Headache / Migraine Emotional Processing Spirituality Randomized Controlled Trial Review Article Safety Adverse Events Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin for Fear of Cancer Recurrence2026-08-01 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization2026-05-13 Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.2024-09-12

Related papers

Long-term transformative effects and integration challenges of psychedelic experiencesConsciousness Spirituality & Transpersonal Psychology · 2022-09-12 Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01 Psilocybin as a healerConsciousness Spirituality & Transpersonal Psychology · 2022-09-12